Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

“Endometrial Cancer – Pipeline Insights, 2015”- A DelveInsight’s Report

  • Home Blog Endometrial cancer pipeline insights 2015 a delveinsights report

“Endometrial Cancer – Pipeline Insights, 2015”- A DelveInsight’s Report

Jul 30, 2015

DelveInsight, the leading market research and consulting company has added a new report “Endometrial Cancer – Pipeline Insights, 2015” to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight. In addition to this, our research expertise provides our clients with up to date information of market till the date of order.

The Endometrial Cancer – Pipeline Insights, 2015 report provides client with details on the ongoing enterprises and the upcoming business opportunities related to new interventions.

Untitled

Key Highlights of the Report:

  • The report gives information of 35+ pipeline drugs with 30+ companies actively involved in drug development. There are 7 drugs which are in pre-clinical phase, 10 in phase I, 8 in phase I/II and 11 in phase II.
  • Aeterna Zentaris is developing a lead product Zoptarelin doxorubicin which is in Phase III.
  • R&D activities and technologies used along with the pipeline molecules in development.
  • Stages of development of pipeline molecules.
  • Therapeutic assessments by molecule types, route of administration, monotherapy and combination products.
  • Information related to collaborations, in-licensing and out-licensing deals.

DelveInsights, Endometrial Cancer-Pipeline Insights, 2015 report provides Endometrial Cancer Landscape across the globe. Therefore the report on Endometrial Cancer-Pipeline Insights provides information on chemical, technology information and comparative analysis at various stages. In addition, it helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight is offering the Report at a price of USD 1,250 as a single user license, USD 2,500 as a site license and USD 4,000 as a Global/Enterprise License.

For more information on Pipeline Insight Reports, email at info@delveInsight.com

About Us

DelveInsight is a leading Business Consulting and Market Research Firm. They help clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.

loader